APA (7th ed.) Citation

M, C. R., JA, T. C., P, C. B., L, E. H., M, P., I, H. S., & J, S. (2025). Characteristics of Patients Receiving Budesonide/Glycopyrronium/Formoterol for Chronic Obstructive Pulmonary Disease in Spain: The AURA Study. International journal of chronic obstructive pulmonary disease, 20, 999. https://doi.org/10.2147/COPD.S490227

Chicago Style (17th ed.) Citation

M, Calle Rubio, Trigueros Carrero JA, Chaparro Briones P, Escudero Herrera L, Pollack M, Hernández Subirá I, and Sánchez-Covisa J. "Characteristics of Patients Receiving Budesonide/Glycopyrronium/Formoterol for Chronic Obstructive Pulmonary Disease in Spain: The AURA Study." International Journal of Chronic Obstructive Pulmonary Disease 20 (2025): 999. https://doi.org/10.2147/COPD.S490227.

MLA (9th ed.) Citation

M, Calle Rubio, et al. "Characteristics of Patients Receiving Budesonide/Glycopyrronium/Formoterol for Chronic Obstructive Pulmonary Disease in Spain: The AURA Study." International Journal of Chronic Obstructive Pulmonary Disease, vol. 20, 2025, p. 999, https://doi.org/10.2147/COPD.S490227.